Episode 18 - What's New Doc? From Data to Decisions: Advancing IPF Care in 2026
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Episode 18 - What's New Doc? From Data to Decisions: Advancing IPF Care in 2026
-
Lu par :
-
De :
Recent advances in idiopathic pulmonary fibrosis (IPF) continue to expand the evidence base, offering important insights into disease biology, therapeutic strategies, and ongoing research. However, clinicians often face challenges in interpreting and applying these insights within the context of evolving IPF care.
In this What's New Doc video, Dr. Steven Nathan reviews the latest clinical trial findings, real-world evidence, and scientific advances shaping the evolving understanding of IPF. By translating emerging data into practical clinical insights, he discusses their impact on disease management, treatment decisions, and the future direction of IPF care in 2026.
Launch/Release Date: July 9, 2026
Activity Expiration Date: June 30, 2027
FACULTY
Steven Nathan, MD
Schar Chair
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
